COSMO Pharmaceuticals N.V. (0RGI) Income Statement
COSMO Pharmaceuticals N.V. Income Statement
Last quarter (Q2 2026), COSMO Pharmaceuticals N.V.'s total revenue was $50.15M, a decrease of 63.19% from the same quarter last year. In Q2, COSMO Pharmaceuticals N.V.'s net income was $-4.74M. See COSMO Pharmaceuticals N.V.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 104.85M | $ 266.79M | $ 92.78M | $ 102.09M | $ 65.07M | |
| $ 48.78M | $ 246.92M | $ 53.44M | $ 83.33M | $ 49.93M | |
| $ 59.27M | $ 98.04M | $ 47.29M | $ 55.27M | $ 21.00M | |
| Depreciation and Amortization | $ 12.76M | $ 12.29M | $ 11.85M | $ 13.86M | $ 7.37M |
| $ 2.27M | $ 165.71M | $ 18.00M | $ 47.49M | $ 18.47M | |
| $ -10.48M | $ 148.88M | $ 6.15M | $ 28.06M | $ 11.10M | |
| $ 9.56M | $ 4.49M | $ -4.61M | $ -3.58M | $ 12.90M | |
| $ -924.00K | $ 153.37M | $ 1.53M | $ 24.47M | $ 24.00M | |
| $ -3.63M | $ 133.24M | $ -4.93M | $ 17.23M | $ 21.67M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.23 | $ 8.15 | $ -0.31 | $ 1.05 | $ 1.29 |
| Diluted EPS | $ -0.23 | $ 8.12 | $ -0.31 | $ 1.05 | $ 1.28 |
| Weighted Average Shares Outstanding | 15.97M | 16.36M | 16.11M | 16.43M | 16.84M |
| Weighted Average Shares Outstanding (Diluted) | 15.97M | 16.42M | 16.11M | 16.43M | 16.90M |
Currency in EUR